.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Chlorpheniramine maleate - Generic Drug Details

« Back to Dashboard
Chlorpheniramine maleate is the generic ingredient in twenty-three branded drugs marketed by Sun Pharm Inds, Pharmavite, Purepac Pharm, Impax Labs, Newtron Pharms, Pharm Assoc, Bel Mar, Schering, Schering Plough, Roxane, Avanthi Inc, Halsey, Vitarine, Bayer Healthcare Llc, Elkins Sinn, Watson Labs, Lederle, Panray, Alza, Lannett, Pharmeral, Pioneer Pharms, Aurolife Pharma Llc, Bell Pharma, Kv Pharm, Glaxosmithkline, Anabolic, Ivax Sub Teva Pharms, Bayer Pharms, Pvt Form, West Ward, Spriaso Llc, Cypress Pharm, Tris Pharma Inc, Paddock Llc, Mayne Pharma Inc, Pfizer, Novartis, Graham Dm, Cent Pharms, Schwarz Pharma, and Fisons, and is included in sixty NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate. Four suppliers are listed for this compound.

Summary for Generic Name: chlorpheniramine maleate

Tradenames:23
Patents:5
Applicants:42
NDAs:60
Drug Master File Entries: see list29
Suppliers / Packaging: see list4
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc
HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride
SOLUTION;ORAL205657-001Aug 3, 2015RXNo► subscribe► subscribe
Pioneer Pharms
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL088556-001Jul 13, 1984DISCNNo► subscribe► subscribe
Pvt Form
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL080786-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: chlorpheniramine maleate

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,576,604► subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,857,330► subscribe
Alza
EFIDAC 24 CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL019746-002Nov 18, 19944,673,405► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc